KCM INVESTMENT ADVISORS LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
KCM INVESTMENT ADVISORS LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,865,771
+29.4%
57,426
+0.3%
0.07%
+26.4%
Q1 2024$1,441,523
-16.6%
57,226
+7.6%
0.05%
-23.2%
Q4 2023$1,727,936
+18.8%
53,200
-0.4%
0.07%
+9.5%
Q3 2023$1,454,883
-44.4%
53,400
-54.6%
0.06%
-40.0%
Q2 2023$2,615,643
+61.2%
117,557
+56.9%
0.10%
+59.1%
Q1 2023$1,622,789
+118179.1%
74,921
+10.9%
0.07%
+11.9%
Q4 2022$1,372
-99.9%
67,5390.0%0.06%
-26.2%
Q3 2022$1,732,000
+7.8%
67,5390.0%0.08%
+14.3%
Q2 2022$1,606,000
+10.8%
67,539
+4.9%
0.07%
+32.1%
Q1 2022$1,449,000
+7.1%
64,357
-5.9%
0.05%
+12.8%
Q4 2021$1,353,000
-8.0%
68,357
-8.5%
0.05%
-20.3%
Q3 2021$1,470,000
+66.7%
74,717
+86.4%
0.06%
+63.9%
Q2 2021$882,000
-7.5%
40,0890.0%0.04%
-14.3%
Q1 2021$954,000
-8.5%
40,089
+0.5%
0.04%
-16.0%
Q4 2020$1,043,000
+50.3%
39,8890.0%0.05%
+31.6%
Q3 2020$694,000
+3.4%
39,8890.0%0.04%0.0%
Q2 2020$671,00039,8890.04%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,360,485$186,0218.91%
Novo Holdings A/S 3,377,768$75,155,3385.81%
Parallel Advisors, LLC 3,726,565$82,916,0712.67%
TANAKA CAPITAL MANAGEMENT INC 35,539$7912.14%
S&T BANK/PA 347,260$7,7271.39%
FAS Wealth Partners, Inc. 310,771$6,914,6550.88%
Birchview Capital, LP 50,000$1,112,5000.83%
Granite Investment Partners, LLC 792,519$17,633,5480.70%
Bridge City Capital, LLC 60,632$1,349,0620.64%
AJ WEALTH STRATEGIES, LLC 509,934$11,346,0320.55%
View complete list of CORCEPT THERAPEUTICS INC shareholders